ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Pharmacosmos A/S clinical trials

Part of Pharmacosmos Holding A/S, which holds 100% as of 2025-04-30. Source

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 54 studies whose lead sponsor is Pharmacosmos A/S or one of 3 companies grouped under it. 5 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 5, 2026.

Our grouping of 4 registry names, not the registry’s. See them and correct one ↓

Compare Pharmacosmos with Boehringer Ingelheim and Amgen →

Pipeline: 2 programs

Each counted once: 2 with a study Pharmacosmos A/S leads registered in the last two years.

  • Phase 4 (approved, new studies)

The 2 programs — sign in to see the list, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Pharmacosmos A/S’ own registered studies; Pharmacosmos A/S’ own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Pharmacosmos A/S’ studies test, most open studies first — 7 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

3 of Pharmacosmos A/S’ studies under way reach primary completion within a year, 2 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. M
  6. 1A
  7. M
  8. J
  9. J
  10. A
  11. S
  12. 2O
  13. N

Add all 3 to your calendar (.ics) → With an account.

All 54 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now59%Recruiting 4 · Not yet recruiting 1
  • Under way, not recruiting12%
  • Completed3870%
  • Stopped early815%Terminated 5 · Withdrawn 3
  • Status unknown or other24%Approved for marketing 1 · Status unknown 1

Phase

  • Phase 324
  • Phase 113
  • Phase 213
  • Phase 44

Where

  • United States23
  • Denmark13
  • Spain6
  • Georgia5
  • United Kingdom5
  • Bulgaria5

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 817
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 126

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Pharmacosmos A/S.

  • Pharmacosmos A/S
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    36 studies
  • G1 Therapeutics, Inc.
    Acquired — became part of Pharmacosmos A/S, Sep 18, 2024 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    16 studies →
  • Abfero Pharmaceuticals, Inc
    Acquired — became part of Pharmacosmos A/S, 2021 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Pharmacosmos UK Ltd
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Focus areas

Conditions Pharmacosmos A/S leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 54. Browse all 54 →